We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Edoxaban

Edoxaban | CAS NO: 480449-70-5, Edoxaban is an oral anticoagulant (blood thinner) that is used primarily for the prevention and treatment of blood clots. It works by inhibiting a clotting factor called Factor Xa, which plays a crucial role in the blood clotting process.

We are the Synchemia Research Chemical specializes in manufacturing and supplying of Edoxaban impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities Edoxaban is prescribed to reduce the risk of stroke and blood clots in patients with non-valvular atrial fibrillation (AF), a condition where the heart's upper chambers beat irregularly, increasing the likelihood of clot formation. Buy Reliable and High-Purity Edoxaban Impurities, Delivered by Synchemia Research Chemicals.

download image Download catalogue

Pharmaceutical Reference Standards

N-Nitroso Edoxaban Impurity 2
N-Nitroso Edoxaban Impurity 2
CAT No SRC-N014041
CAS No NA
Mol.F. C6H7N3OS
Mol.Wt. 169.20g/mol
INV STATUS IN STOCK
N-Nitroso Edoxaban Impurity 3
N-Nitroso Edoxaban Impurity 3
CAT No SRC-N014044
CAS No NA
Mol.F. C8H9N3O3S
Mol.Wt. 227.2 g/mol
INV STATUS IN STOCK
N-Nitroso Edoxaban Impurity 4
N-Nitroso Edoxaban Impurity 4
CAT No SRC-N014042
CAS No NA
Mol.F. C6H6BrN3OS
Mol.Wt. 248g/mol
INV STATUS IN STOCK
N-Nitroso Edoxaban Impurity 5
N-Nitroso Edoxaban Impurity 5
CAT No SRC-N014045
CAS No NA
Mol.F. C7H7N3O3S
Mol.Wt. 213.2 g/mol
INV STATUS IN STOCK
N-Nitroso Edoxaban Desmethyl Impurity
N-Nitroso Edoxaban Desmethyl Impurity
CAT No SRC-N014046
CAS No NA
Mol.F. C23H27ClN8O5S
Mol.Wt. 563 g/mol
INV STATUS IN STOCK
Edoxaban Desmethyl Impurity
Edoxaban Desmethyl Impurity
CAT No SRC-E5004
CAS No 778571-11-2
Mol.F. C23H28ClN7O4S
Mol.Wt. 534 g/mol
INV STATUS IN STOCK
Edoxaban Impurity 56
Edoxaban Impurity 56
CAT No SRC-E5030
CAS No NA
Mol.F. C24H30ClN7O5S
Mol.Wt. 564.1 g/mol
INV STATUS CUSTOM SYNTHESIS
Edoxaban Impurity 62
Edoxaban Impurity 62
CAT No SRC-E5033
CAS No 617-97-0
Mol.F. C7H8O3S
Mol.Wt. 172.2 g/mol
INV STATUS IN STOCK
Edoxaban Impurity 109
Edoxaban Impurity 109
CAT No SRC-E5034
CAS No 1190987-12-2
Mol.F. C7H8N2O2S
Mol.Wt. 184.2 g/mol
INV STATUS IN STOCK
Edoxaban Impurity 38
Edoxaban Impurity 38
CAT No SRC-E5035
CAS No 39620-04-7
Mol.F. C5H5ClN2 
Mol.Wt. 128.6 g/mol
INV STATUS IN STOCK
Edoxaban Impurity 70
Edoxaban Impurity 70
CAT No SRC-E5036
CAS No 259809-24-0
Mol.F. C7H10N2S
Mol.Wt. 154.2 g/mol
INV STATUS IN STOCK
Edoxaban Impurity 35
Edoxaban Impurity 35
CAT No SRC-E5037
CAS No 852291-41-9
Mol.F. C7H11N3S : 2(HBr)
Mol.Wt.  169.3 : 2(80.9) g/mol
INV STATUS IN STOCK
(1R, 2S, 5R)-tert-Butyl Edoxaban
(1R, 2S, 5R)-tert-Butyl Edoxaban
CAT No SRC-E5038
CAS No 2024614-32-0
Mol.F. C21H30ClN5O5 
Mol.Wt. 468g/mole
INV STATUS CUSTOM SYNTHESIS
(1R, 2S, 5S)-tert-Butyl Edoxaban
(1R, 2S, 5S)-tert-Butyl Edoxaban
CAT No SRC-E5039
CAS No 480452-36-6
Mol.F. C21H30ClN5O5 
Mol.Wt. 468g/mole
INV STATUS CUSTOM SYNTHESIS
2,4-di-epi-Edoxaban
2,4-di-epi-Edoxaban
CAT No SRC-E5040
CAS No 1255529-28-2
Mol.F. C24H30ClN7O4S
Mol.Wt. 548.1g/mole
INV STATUS CUSTOM SYNTHESIS
4-epi-Edoxaban
4-epi-Edoxaban
CAT No SRC-E5041
CAS No 1255529-26-0
Mol.F. C24H30ClN7O4S
Mol.Wt. 548.1g/mole
INV STATUS CUSTOM SYNTHESIS

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.